Your browser doesn't support javascript.
loading
Relationships Between Stigma, Risk Tolerance, and Buprenorphine Dispensing Intentions Among Community-Based Pharmacists: Results From a National Sample.
Light, Alysson E; Green, Traci C; Freeman, Patricia R; Zadeh, Paria Sanaty; Burns, Anne L; Hill, Lucas G.
Afiliación
  • Light AE; University of Chicago, Chicago, IL, USA.
  • Green TC; Brandeis University, Waltham, MA, USA.
  • Freeman PR; University of Kentucky, Lexington, KY, USA.
  • Zadeh PS; American Pharmacists Association, Washington, DC, USA.
  • Burns AL; American Pharmacists Association, Washington, DC, USA.
  • Hill LG; The University of Texas at Austin, Austin, TX, USA.
Subst Use Addctn J ; 45(2): 211-221, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38258805
ABSTRACT

BACKGROUND:

Concerns have been raised that pharmacists sometimes act as barriers to patients with opioid use disorder (OUD) accessing buprenorphine treatment. The present research explores how community pharmacists' endorsement (vs non-endorsement) of stigmatizing beliefs about patients taking buprenorphine relate to intentions, comfort, and decisions regarding dispensing buprenorphine for OUD. In addition, we assessed attitudes toward risk in pharmacy practice as a novel correlate of dispensing intentions and decisions.

METHODS:

A sample of 207 active community-based pharmacists practicing in the United States responded to survey items measuring stigma, risk tolerance, and intentions to dispense buprenorphine. The survey included 2 vignettes in which patients presented to the pharmacy with a prescription for buprenorphine, and respondents rated their comfort with dispensing and decisions regarding dispensing in the vignette.

RESULTS:

Results suggest that both stigma toward patients taking buprenorphine to treat OUD and tolerance for risk in pharmacy settings are related to differences in pharmacists' intentions to and willingness to dispense buprenorphine for OUD.

CONCLUSIONS:

Findings support the need for interventions to reduce stigma associated with buprenorphine use among pharmacists and suggest that risk tolerance is an important determinant of pharmacists' behavior that merits further study.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Servicios Farmacéuticos / Buprenorfina / Trastornos Relacionados con Opioides Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Subst Use Addctn J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Servicios Farmacéuticos / Buprenorfina / Trastornos Relacionados con Opioides Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Subst Use Addctn J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos